Biocept (BIOC) Reports Q2 Loss of $0.20
Tweet
Share
E-mailGet Alerts BIOC Hot Sheet
Join SI Premium – FREE
Biocept (NASDAQ: BIOC) reported Q2 EPS of ($0.20), versus ($0.20) reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Helius Medical Technologies (HSDT) Misses Q2 EPS by 31c
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
